Skeletal muscle has the ability to change fiber size, contractile velocity, and myosin composition in response to a wide variety of stimuli. This renewal application will continue to focus on the properties and functions of the myosin heavy chain (MyHC) motor proteins that are expressed in skeletal muscle and that play a role in this plasticity. In mammals, striated muscle MyHCs are encoded by at least 9 closely related genes. Recently, 23 different mutations in the embryonic, perinatal, Ha, and (3 MyHC genes have been shown to cause 6 distinct skeletal myopathies. However, the mechanisms by which these mutations cause disease and their specific effects on each protein are not understood. We have recently achieved the long-sought goal of expressing and purifying recombinant, enzymatically active human skeletal myosin motor domains (both wild type and disease-causing mutants). Here, we propose a tripartite study of skeletal myosins and disease-causing mutations in them:
In Aim I, these recombinant motors will be studied biochemically and biophysically.
In Aim II, full-length myosins will be studied in a cultured cell system for the effects of mutations on sarcomere structure and stability.
In Aim III we propose studies in functioning skeletal muscles. We have established transgenic nematodes for characterizing this relatively large number of disease-causing alleles rapidly; the most interesting subset of mutations will then be analyzed in transgenic mice. In previous work funded by this grant, we generated mice that were null for MyHCs lid and Mb; their properties have revealed a great deal about the regulation and function of these genes. Mice null for the MyHC Ma gene have recently been obtained by transposon mutagenesis and provided to us. Our early work shows that they are quite distinct from the other myosin nulls. Here we propose to analyze MyHC Ma null mice to complete the genetic analysis of all 3 adult fast MyHC genes. We will test the hypothesis that absence of MyHC lla results in respiratory dysfunction and an inability of muscle to adapt to exercise. Lay Statement: Muscle function is essential for activities such as breathing, walking, eating and for the beating of the heart. Many diseases affect muscle function and our work focuses on how normal muscle works and how mutant genes caused muscle disease. ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM029090-27
Application #
7460769
Study Section
Skeletal Muscle and Exercise Physiology Study Section (SMEP)
Program Officer
Deatherage, James F
Project Start
1981-09-01
Project End
2011-05-31
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
27
Fiscal Year
2008
Total Cost
$400,318
Indirect Cost
Name
University of Colorado at Boulder
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
007431505
City
Boulder
State
CO
Country
United States
Zip Code
80309
Mijailovich, Srbolujub M; Nedic, Djordje; Svicevic, Marina et al. (2017) Modeling the Actin.myosin ATPase Cross-Bridge Cycle for Skeletal and Cardiac Muscle Myosin Isoforms. Biophys J 112:984-996
Soto, Susan M; Blake, Amy C; Wesolowski, Stephanie R et al. (2017) Myoblast replication is reduced in the IUGR fetus despite maintained proliferative capacity in vitro. J Endocrinol 232:475-491
Walklate, Jonathan; Ujfalusi, Zoltan; Geeves, Michael A (2016) Myosin isoforms and the mechanochemical cross-bridge cycle. J Exp Biol 219:168-74
Feinstein-Linial, Miora; Buvoli, Massimo; Buvoli, Ada et al. (2016) Two novel MYH7 proline substitutions cause Laing Distal Myopathy-like phenotypes with variable expressivity and neck extensor contracture. BMC Med Genet 17:57
Blenck, Christa L; Harvey, Pamela A; Reckelhoff, Jane F et al. (2016) The Importance of Biological Sex and Estrogen in Rodent Models of Cardiovascular Health and Disease. Circ Res 118:1294-312
Walklate, Jonathan; Vera, Carlos; Bloemink, Marieke J et al. (2016) The Most Prevalent Freeman-Sheldon Syndrome Mutations in the Embryonic Myosin Motor Share Functional Defects. J Biol Chem 291:10318-31
Peter, Angela K; Bjerke, Maureen A; Leinwand, Leslie A (2016) Biology of the cardiac myocyte in heart disease. Mol Biol Cell 27:2149-60
Pugach, Emily K; Blenck, Christa L; Dragavon, Joseph M et al. (2016) Estrogen receptor profiling and activity in cardiac myocytes. Mol Cell Endocrinol 431:62-70
Pugach, Emily K; Richmond, Phillip A; Azofeifa, Joseph G et al. (2015) Prolonged Cre expression driven by the ?-myosin heavy chain promoter can be cardiotoxic. J Mol Cell Cardiol 86:54-61
Nag, Suman; Sommese, Ruth F; Ujfalusi, Zoltan et al. (2015) Contractility parameters of human ?-cardiac myosin with the hypertrophic cardiomyopathy mutation R403Q show loss of motor function. Sci Adv 1:e1500511

Showing the most recent 10 out of 106 publications